Transfusion-related adverse events in the Platelet Dose study

Transfusion

Volumn 55, Issue 1, 2015, Pages 144-153

  Kaufman, Richard M ^a   Assmann, Susan F ^b   Triulzi, Darrell J ^c   Strauss, Ronald G ^d   Ness, Paul ^e   Granger, Suzanne ^b   Slichter, Sherrill J ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; APHERESIS; ARTICLE; BLOOD TRANSFUSION REACTION; CHILD; CHILL; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; FEVER; HEMOLYSIS; HUMAN; HYPERTENSION; HYPOPROLIFERATIVE THROMBOCYTOPENIA; HYPOTENSION; HYPOXIA; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; RANDOMIZED CONTROLLED TRIAL; RIGOR; SINUS BRADYCARDIA; SINUS TACHYCARDIA; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; WHEEZING; ADVERSE EFFECTS; BIOLOGICAL MODEL; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; HEMATOLOGIC DISEASES; HEMORRHAGE; IMMUNOLOGY; LEUKAPHERESIS; MIDDLE AGED; NEOPLASMS; PRESCHOOL CHILD; TACHYCARDIA, SINUS; THROMBOCYTOPHERESIS; TRANSFUSION REACTION; YOUNG ADULT;

BLOOD GROUP ABO SYSTEM;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEVER; HEMATOLOGIC DISEASES; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE REDUCTION PROCEDURES; MIDDLE AGED; MODELS, IMMUNOLOGICAL; NEOPLASMS; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; TACHYCARDIA, SINUS; THROMBOCYTOPENIA; TRANSFUSION REACTION; YOUNG ADULT;

EID: 84920923803     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12791     Document Type: Article

References (18)

1. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600-613.
2. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
3. Zelen M,. The randomization and stratification of patients to clinical trials. J Chronic Dis 1974; 27: 365-375.
4. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. 2003. [cited 2003 Jun 10]. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf
5. Lindstrom MJ, Bates DM,. Newton-Raphson and EM algorithms for linear mixed effects models for repeated measures data. J Am Stat Assoc 1988; 83: 1014-1021.
6. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625-628.
7. Xiao W, Tormey CA, Capetillo A, et al. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components. Vox Sang 2013; 105: 334-340.
8. Geiger TL, Howard SC,. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev 2007; 21: 1-12.
9. Kennedy LD, Case LD, Hurd DD, et al. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion 2008; 48: 2285-2291.
10. Marti-Carvajal AJ, Sola I, Gonzalez LE, et al. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. Cochrane Database Syst Rev 2010;(6): CD007539.
11. Tobian AA, King KE, Ness PM,. Transfusion premedications: a growing practice not based on evidence. Transfusion 2007; 47: 1089-1096.
12. Savage W, Tobian AA, Ness PM, et al. Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets. Transfusion 2014; 54: 496-498.
13. Maunsell K,. Desensitization in allergic recipients after serum transfusions. Br Med J 1944; 2: 236-239.
14. Julmy F, Ammann RA, Taleghani BM, et al. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs. Transfusion 2009; 49: 21-33.
15. Triulzi DJ, Assmann SF, Strauss RG, et al. The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. Blood 2012; 119: 5553-5562.
16. Shehata N, Tinmouth A, Naglie G, et al. ABO-identical versus nonidentical platelet transfusion: a systematic review. Transfusion 2009; 49: 2442-2453.
17. Savage WJ, Tobian AA, Fuller AK, et al. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011; 51: 1716-1722.
18. Savage WJ, Hamilton RG, Tobian AAR, et al. Defining risk factors and presentations of allergic reactions to platelet transfusion. J Allergy Clin Immunol 2014; 133: 1772-1775.e9.